Should We Be Doing Molecular Testing at the Time of Acquired Resistance? Should We Be Doing Molecular Testing at the Time of Acquired Resistance?
A study of ALK-positive lung cancer raises questions about the role of repeat biopsies, as well as the relative value of tissue versus plasma molecular testing.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news